Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Antibiotic Exposure, Not Alloreactivity, Is the Major Driver of Microbiome Changes in Hematopoietic Cell Transplantation

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.12.015Source: DataRank Database

Antibiotic Exposure, Not Alloreactivity, Is the Major Driver of Microbiome Changes in Hematopoietic Cell Transplantation is a research paper published in Transplantation and Cellular Therapy (2021). On theSindex it has a DataRank of 0. It has been cited 23 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access23 citations

Download PDF

Cite:

Linked data & code

bioproject doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: hybridTopics (19)IDs (PubMed, PMC)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Heekuk Park ORCID,Cristian Taborda,Christian Gordillo ORCID,Markus Y. Mapara ORCID,Amer Assal ORCID

Live enrichment

PubMed:34958974 PMC:PMC8923982

National Institutes of Health

Grant: R01 AI116939

National Institutes of Health

Grant: R01 HL143424

National Institutes of Health

Grant: 3R01AI116939-02S1

Carbapenem-resistant bacterial colonization and infection after liver transplant

National Institutes of Health

Grant: 5R01HL143424-04

Effector T-cell trafficking in graft-versus-host disease

Atara Biotherapeutics

Astellas Pharma US

Gilead Sciences

hybridLicense: cc-by-nc-nd

publisherhttps://www.sciencedirect.com/science/article/pii/S2666636721014482/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2666636721014482?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666636721014482?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8923982

Unpaywallhttps://doi.org/10.1016/j.jtct.2021.12.015

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

HumansAnti-Bacterial AgentsTransplantation ConditioningHematopoietic Stem Cell TransplantationTransplantation, HomologousGastrointestinal Microbiome

Keywords

AntibioticsAllogeneic transplantationAutologous TransplantationMicrobiomeTransplantation ConditioningHematopoietic Stem Cell TransplantationHumansTransplantation, HomologousAnti-Bacterial AgentsGastrointestinal Microbiome

Sustainable Development Goals

SDG 3: 3. Good health

Antibiotic Exposure, Not Alloreactivity, Is the Major Driver of Microbiome Changes in Hematopoietic Cell Transplantation

FAIR Checklist

Authors (8)

Funding (7 grants)

Open Access

Topics

Annotations (Europe PMC)